Use of Tetanus-diphtheria (Td) vaccine in Children 4–7 years of Age: World Health Organization Consultation of Experts
Tetanusprofylaxe na verwonding | NTvG
Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age? | PLOS
Asplenie | LCI richtlijnen
Vaccines | Free Full-Text | Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
Association between season of vaccination and antibody levels against infectious diseases | Epidemiology & Infection | Cambridge Core
PDF) The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: A cross-sectional questionnaire study
Tetanus | RIVM
Tetanus | LCI richtlijnen
RVP-richtlijn Vaccineren van prematuren in het kader van het RVP | Rijksvaccinatieprogramma.nl
National Immunisation Programme | RIVM
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination | eLife
Tetanus | RIVM
Stroomschema Tetanus-PEP 2020 - RIVM CIb/LCI 5 augustus 2020 Bijlage bij LCI-richtlijn Tetanus - Studeersnel
Ag-specific serum Ig levels prior to and post-aP booster vaccination.... | Download Scientific Diagram
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination | eLife
Fast, Antigen-Saving Multiplex Immunoassay To Determine Levels and Avidity of Mouse Serum Antibodies to Pertussis, Diphtheria, a
Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers | PLOS ONE
Asplenie | LCI richtlijnen
PDF) Præventis, the immunisation register of the Netherlands: a tool to evaluate the National Immunisation Programme
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence | Future Microbiology
Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries | Nature Communications
